TLR7 and neoplasm: The M3-day 1687 time point (tumor locally treated with  TLR7 agonist) showed convolution of T cell repertoires with a greater TCR network connectivity than the previous time points, based on metrics such as density, average clustering coefficient and S-metric (Supplementary Fig. 2b).